ZeCardio Therapeutics (ZeCardioTx), a Barcelona based pharma company focused on the discovery of cardiovascular drugs using the zebrafish model and an innovative, proprietary screening and analysis platform, ZeCardio®, selected Taros Chemicals’ SVP Drug Discovery, Dr. Torsten Hoffmann, to join the…
Home
Drug Discovery
Taros’ international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular...
medicinal chemistry
Drug Discovery
Material Science
As a leading Contract Research Organization in Europe, Taros provides valuable contract discovery for synthetic organic chemistry, chemical process development, and pilot plant manufacturing services to meet our clients’ needs at…
synthetic organic chemistry
Custom synthesis
Material Science
We create performance chemicals to enhance new materials, plastics, coatings, dyes & inks, cosmetics, flavors and many more research and industrial applications...
performance chemicals
Material Science
Latest News
Read more
The 17th edition of Annual Discovery on Target (DOT), the industry’s premier event for novel drug targets and technologies, will bring together more than 1,300 drug discovery experts from September 16 to 19, 2019 in Boston, Massachusetts USA. Target Validation Strategies for the Discovery and…
For nearly two decades, the BioJapan exhibition has played an pivotal role in promoting interaction between Japan and global organizations and in spuring new business opportunities. In October 2019, the world’s top business development, licensing and alliance management, R&D…
Dario Valenti, Stanimira Hristeva, Christian Ottmann, Anna Karawajczyk
Taros
We are transforming your ideas into products
At Taros we regularly perform complex multi-step or enantioselective syntheses with an emphasis on developing and synthesizing novel building blocks, intermediates and final compounds for several applications. We pride ourselves on a 20 year track record of success in supporting diverse industries with their chemistry and innovation challenges. Our scientists specialize in organic and organometallic synthesis including polymers, from lab to pilot quantities. Taros operates a customer-centric and flexible business model providing our diverse clients with customized innovative chemistry services:
We provide long-term added value to our diverse customers through cutting-edge and innovative chemistry-based technologies
Taros creates holistic and cost-effective solutions of the highest quality and reliability for the global marketplace. We are inspired to provide exceptional added value to our customers’ R&D processes by anticipating hurdles foreseeing cost and lead time reductions. tThereby we facilitate competitive and “early-to-market” advantages. With our state-of-the-art lab facilities and our scientists (of which 65% hold a Ph.D. in Chemistry), we are committed to serve the diverse needs of our customers in drug discovery, custom synthesis and specialty or performance chemicals. More than 13,000 synthesis, research and process chemistry projects have been delivered successfully to our ever-growing global customer base.
